Skip to content
OpenCapital
Get started

Bolt Biotherapeutics, Inc. BOLT Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$2.2MBeat by $1.3M
EPS-$3.72Beat by $1.35
Revenue estimate$820.8K
EPS estimate-$5.07

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$500.0K
EPS estimate-$3.39

Versus estimates

Revenue

Q1 2026$26.0KMiss by $1.5MQ4 2025$2.5MBeat by $1.8M
Q3 2025$2.2MBeat by $1.3M
Q2 2025$1.8MBeat by $958.2KQ1 2025$1.2MBeat by $454.5KQ4 2024$10.0KMiss by $780.0K

Diluted EPS

Q1 2026-$4.31Miss by $1.46Q4 2025-$3.84Beat by $0.46
Q3 2025-$3.72Beat by $1.35
Q2 2025-$4.46Beat by $1.94Q1 2025-$5.80Beat by $1.00Q4 2024-$7.60In line

Ask the moment Bolt Biotherapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bolt Biotherapeutics, Inc. report Q3 2025 earnings?
Bolt Biotherapeutics, Inc. (BOLT) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Bolt Biotherapeutics, Inc.'s Q3 2025 revenue and EPS?
Bolt Biotherapeutics, Inc. reported revenue of $2.2M and eps of $-3.72 for Q3 2025.
Did Bolt Biotherapeutics, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $820.8K by $1.3M. EPS beat the consensus estimate of $-5.07 by $1.35.
How did Bolt Biotherapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 90.1% from $1.1M a year earlier and eps declined 830.0% from $-0.40.
Where can I find Bolt Biotherapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-277521) and the 10-Q periodic report (0001193125-25-277549) directly on SEC EDGAR. The filing index links above go to sec.gov.